Doshi, Ami <br/><br/>
The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).  [electronic resource] 

 -  Seton Hall law review  2007 
 - 625-60 p.  digital 
<br/><br/> Publication Type: Historical Article; Journal Article 
<br/><br/><label>ISSN: </label>0586-5964 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abnormalities, Drug-Induced--prevention & control<br/>Acne Vulgaris--drug therapy<br/>Adverse Drug Reaction Reporting Systems--instrumentation<br/>Contraindications<br/>Cost-Benefit Analysis<br/>Drug Approval<br/>Drug and Narcotic Control--history<br/>Female<br/>Fetus<br/>Guidelines as Topic<br/>History, 20th Century<br/>History, 21st Century<br/>Humans<br/>Isotretinoin--administration & dosage<br/>Legislation, Pharmacy<br/>Male<br/>Maternal-Fetal Exchange<br/>Pharmaceutical Services--standards<br/>Pregnancy--drug effects<br/>Reproductive Behavior<br/>Risk Management--methods<br/>Skin Diseases--drug therapy<br/>Social Control Policies--economics<br/>United States<br/>United States Food and Drug Administration